CLINICAL PROFILE OF HOSPITALISED IRRITABLE BOWEL SYNDROME PATIENTS IN INDIA

Received 2023-03-17; Accepted 2023-07-28; Published 2024-01-02

Authors

  • Nitin Joseph Department of Community Medicine, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
  • Rhea Simon Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
  • Anirudh Nambiar Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
  • Snehi Sinha Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
  • Adith Reddy Bondugula Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
  • Akhil Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
  • Ritika Bhatia Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
  • Manvi Shahi Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.

DOI:

https://doi.org/10.22452/jummec.vol27no1.5

Abstract

Introduction: Irritable bowel syndrome (IBS) is the most frequent functional gastrointestinal disorder. However due to poor health-seeking behaviour of the people and difficulties faced by medical professionals to diagnose IBS, it remains an under-diagnosed gastrointestinal disorder.
Objectives: To study the risk factors, clinical presentation, and management of IBS among in-patients admitted at two tertiary care hospitals in Mangalore.
Methods: Forty-one patients diagnosed with IBS based on ROME IV criteria between January 2017 to March 2021 were included. A semi-structured proforma was used to collect the required information.
Results: The mean age at diagnosis among the patients was 44.6 ± 17.8 years. Twenty-four (58.5%) of them were females. Family history of IBS was present among five (12.2%) patients. IBS-M [18 (43.9%)] was the most common type. Alarming signs like blood and mucus in the stools were present each among eight (19.5%) patients. Weight loss was the most common extra-intestinal symptom [nine (21.9%)]. Mental health problems and psychosomatic disorders were present among seven (17.1%) and six (14.6%) patients, respectively. The most common drug used to treat constipation was Ispaghula husk [17 (41.5%)], and to treat diarrhoea was Loperamide [14 (34.1%)]. As many as 15 (36.6%) patients did not improve with treatment. None of the patients were put on non-pharmacological therapies.
Conclusion: Holistic management of alarming signs such as blood and mucus in the stools and extra-intestinal symptoms like weight loss is required among IBS patients. Various mental health problems and psychosomatic disorders need to be screened and treated as a part of its management. Non-pharmacological therapies need to be also introduced to improve its treatment outcomes.

Downloads

Download data is not yet available.

Downloads

Published

2024-01-02

Issue

Section

Research article